Across TCGA patient cohorts, OR1C1 RNA expression is significantly associated with the go_rna of many other GO terms, with 6,007 significant associations in total. STAD shows the largest number of these associations.

The most reproducible OR1C1-associated GO terms across cancer lineages are Peptidyl-lysine modification, rRNA methylation, and Transcription initiation at RNA polymerase II promoter. Each is linked with OR1C1 in more than 9 cancer types. Because this analysis shows association rather than direction, both OR1C1-to-partner and partner-to-OR1C1 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (OR1C1→partner) and Y-score (partner→OR1C1) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
STAD	Peptidyl-lysine modification →	+0.080	+0.036	<.001	.002	3	9
STAD	rRNA methylation →	+0.073	+0.041	<.001	.002	2	10
STAD	Transcription initiation at RNA polymerase II promoter →	+0.084	+0.045	<.001	.002	3	8
STAD	Mitochondrial gene expression →	+0.102	+0.025	<.001	.001	3	8
STAD	rRNA modification →	+0.082	+0.037	<.001	.002	3	8
STAD	Nucleobase-containing compound transport →	+0.096	+0.034	<.001	.001	3	8

Each partner links to its Q-omics profile. Showing the 6 strongest of 6,007 associations by consensus.

Exploration

OR1C1 survival (RNA) · tumor vs normal (RNA) · all OR1C1 data types